GHRD, which is defined by the body's inability to use its growth hormone and leads to stunted development, has been linked in mice to a 40 per cent increase in longevity and decreased risk of numerous age-related disorders. However, the risk of cardiovascular illness in individuals with GHRD
Drugs that target opioid receptors can have serious adverse effects. Every day, thousands of people worldwide die as a result of opioid overdoses, including fentanyl.
As in animals, plants have immune responses that help them defend against pathogens such as viruses, bacteria, fungi, and oomycetes. Before invaders can be stopped, they must first be detected, and this is accomplished by pattern recognition receptors located on the surface of plant cells
Researchers discovered that a receptor protein called CHRM1 plays an important role in prostate cancer cells' resistance to docetaxel, a routinely used chemotherapeutic treatment to treat advanced cancer that has progressed beyond the prostate.
Research published in 'Diabetes' showed that a glucagon-like peptide-1 receptor (GLP-1R) agonist, a kind of medicine used to treat type 2 diabetes and obesity, can lead to a quick increase in insulin sensitivity.
A research team led by Associate Professor Hidenori Nishihara from Kindai University and Professor Yoshiro Ishimaru from Meiji University, Japan, have identified five new, previously undiscovered groups within the TAS1R family. This discovery is a result of a genome-wide survey of jawed vert
A preclinical study conducted by Weill Cornell Medicine researchers reveals that a certain human genetic variant of a receptor that increases insulin release may help individuals be more resistant to obesity. The researchers revealed that this version operates differently in the cell, which
Patients with multiple myeloma who received idecabtagene vicleucel, popularly known as "ide-cel," a chimeric antigen receptor (CAR) T-cell treatment, had no difference in overall survival outcomes regardless of race or ethnicity.
According to a study published in Blood Advances, patients with multiple myeloma who received idecabtagene vicleucel, also known as "ide-cel," a chimeric antigen receptor (CAR) T-cell treatment, exhibited no change in overall survival outcomes regardless of race or ethnicity.
Men appeared to experience greater rates of severe sickness and mortality at the beginning of the COVID pandemic, which led researchers to hypothesise a connection between androgen receptors—which bind to hormones like testosterone—and SARS-CoV-2 virus infection